Novavax begins human trials of coronavirus vaccine in Australia
Shortpedia
Content Team
Image Credit: shortpedia
Novavax, an American biotech company, on Monday announced that it has started the phase 1/2 clinical trial of its experimental coronavirus vaccine, joining a handful of candidates that are currently being tested on humans globally. The aim of the trial is to assess whether the COVID-19 vaccine candidate, NVX‑CoV2373, is safe and generates an immune response in people. It is engineered from the genetic sequence of SARS‑CoV‑2.
